IRCT2014101618966N2已完成未知
The Prevention of Blindness in Retinopathy of Prematurity by Intravitreal Injection of Bevacizumab
o sponsor0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 days 至 3 months（—）
- 性别
- All
入选标准
- •all the premature new borns that received intravitreal bevacizumab injections for retinopathy of prematurity
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Prevention of vision loss in patients with age-related neovascular macular degeneration by intravitreal injection of bevacizumab and ranibizumab in a typical outpatient setting - VIBERAEUCTR2007-004721-23-DEKlinikum Bremen-Mitte gGmbH
已完成
不适用
Analysis of Risk factors for Retinopathy of Prematurity in AGA vs SGA Preterm infantsCTRI/2020/04/024682Dr Arya Sandesh Wagle350
尚未招募
不适用
Predictors of ophthalmological problem requiring treatment in preterm infantsCTRI/2021/02/031111Sri Ramachandra Institute of Higher Education and Research
招募中
不适用
Screening of retinopathy of prematurityCTRI/2017/02/007842GOVERNMENT MEDICAL COLLEGE AND SIR TAKHTSINHJI50
撤回
不适用
ight restriction in retinal degeneratioACTRN12609000826246Dr John Grigg15